D47. Neonatal and Rare Lung Diseases 2009
DOI: 10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5965
|View full text |Cite
|
Sign up to set email alerts
|

Familial Neuroendocrine Cell Hyperplasia of Infancy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
28
0
4

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(33 citation statements)
references
References 0 publications
1
28
0
4
Order By: Relevance
“…(1,6,14) Similarly, all infants in the present series were born full term and most were male; however, 50% presented symptoms in the neonatal period, showing an earlier onset of the disease in relation to other series. The early presentation of the illness observed in the present series suggests that a possible genetic cause is involved in its pathogenesis, since familial cases have been described in the literature.…”
Section: Discussionsupporting
confidence: 59%
“…(1,6,14) Similarly, all infants in the present series were born full term and most were male; however, 50% presented symptoms in the neonatal period, showing an earlier onset of the disease in relation to other series. The early presentation of the illness observed in the present series suggests that a possible genetic cause is involved in its pathogenesis, since familial cases have been described in the literature.…”
Section: Discussionsupporting
confidence: 59%
“…The trend toward worsening or improvement, age at presentation, immunocompetence, and family history (i.e., whether there are other family members with adult ILD, chILD diagnoses, or a history of neonatal respiratory failure) are also important factors (10,(21)(22)(23)(24). Regarding disease severity, this judgment may be based upon the degree of symptoms (25) and gas exchange abnormalities, or the presence of echocardiographic evidence of pulmonary hypertension (26).…”
Section: Diagnostic Evaluation Overviewmentioning
confidence: 99%
“…A limitation of our study is that it is unknown whether these findings in individuals heterozygous for the NKX2.1 mutation will be generalizable to the entire NEHI population or even other familial occurrences identified (17). Furthermore, it is unknown whether there may be genotype-phenotype correlations in NEHI that could explain the variation in the pattern of clinical findings and natural history of NEHI that is increasingly being observed.…”
Section: Brief Communicationmentioning
confidence: 93%